AKT1 and non-small cell lung carcinoma: The prominent enrichment in the PI3K/Akt pathway and other cancer-associated signaling cascades suggests that isalpinin exerts its anticancer effects by modulating these pivotal oncogenic signaling networks in NSCLC.